ENहिन्दी soon
Home/India/Answers/Constipation on a GLP‑1
INIndia Side effects and safety

What helps constipation on Mounjaro or Ozempic?

GLP Guidebook teamUpdated 5 Oct 202615 sourcesWritten from published sources
The short answer

Fluids, slowly added fibre and movement come first, then laxatives, in a 2023 consensus and 2025 US advisory. In US label diabetes trials, 6% to 7% on Mounjaro (tirzepatide) and 3% to 5% on Ozempic (semaglutide) got constipated. On a dummy injection, 1% to 1.5% did. On semaglutide 2.4 mg (Wegovy's weight-loss dose), a typical bout lasted 47 days.

Before you go further
  • GLP‑1 medicines such as Mounjaro and Ozempic are prescription-only in India, not sold over the counter.13
  • A government statement on 1 Apr 2026 said only endocrinologists, internal-medicine specialists and cardiologists can prescribe them.13 CDSCO expert-committee minutes attach a similar condition to some approvals (endocrinologist or internal-medicine specialist), but we found no rule covering every brand.14
  • The risks are in Guide 5: Side effects and risks.
  • Nothing here promises any result.

How common is constipation on Mounjaro or Ozempic, and how long does it last?

In US label diabetes trials, 6% to 7% on Mounjaro and 3% to 5% on Ozempic got constipated, against 1% to 1.5% on placebo.2,15

Placebo means a dummy injection. Ozempic's figures are for its 0.5 mg (5%) and 1 mg (3%) doses.15

Weight-loss doses are higher, and so are the figures. The Zepbound label (US, tirzepatide for weight) reports 11% to 17%, against 5% on placebo.1 In 3 trials of semaglutide 2.4 mg, the Wegovy dose, 24% got constipated, against 11%.3 A typical bout lasted 47 days, against 35 on placebo, and it stayed more common for all 68 weeks.3 We found no published bout length for tirzepatide.

In 7 Lucknow clinics, 12 of 71 people with diabetes on tirzepatide (17%) reported constipation.4 That study had no comparison group, and 6 authors declared fees from Eli Lilly.4

What does published advice say helps?

A 2023 expert consensus and a 2025 US nutrition advisory both start with enough fluids, fibre from food and more movement.5,6

These medicines may change how fast the gut moves, which could explain why constipation lasts.3 The consensus adds that feeling full makes people drink less water.5

For constipation, the advisory suggests adding fibre gradually, such as prunes or other dried fruit.6 Its tip to go easy on high-fibre food in the first days is for nausea, not constipation.6

For Indian meals, the ICMR-NIN 2024 dietary guidelines name whole wheat roti, millets, beans and lentils as rich in fibre.8 They say fibre "reduces constipation", though they were written for everyone, not GLP‑1 users.8 The NHS (UK) suggests a daily walk or run, a regular toilet time, not delaying when the urge comes, and resting your feet on a low stool.9 More on food is in Guide 8: Life on a GLP‑1.

When do laxatives come in?

When food, fluid and activity changes are not enough, the US advisory lists fibre supplements, stool softeners and other laxatives.6

The consensus says a doctor may lower the GLP‑1 dose if constipation gets worse.5 India's ESI 2025 guideline asks doctors to cut back gut-upsetting medicines such as iron, calcium and opioid painkillers.7

The NHS says laxatives should only be used for a short time.9 The advisory warns that some anti-nausea medicines can make constipation worse.6

The NHS lists reasons to see a GP, including constipation that is "not getting better with treatment", blood in your poo and weight loss without trying.9

Take your constipation questions to the appointment

Build a list of questions to ask. Free, no sign-up.

Make my list

When is constipation an emergency?

Constipation needs urgent care when it comes with stomach pain, bloating or vomiting, or you cannot pass stool or wind.10,12

These can be signs of a blocked bowel. The US Mounjaro label lists reports after approval of blocked bowel (ileus) and severe constipation with stuck stool (faecal impaction).2 The EU Ozempic leaflet calls bowel obstruction "a severe form of constipation" with stomach ache, bloating or vomiting.10 India's government lists bowel obstruction among the severe complications of GLP‑1 medicines.13

Diarrhoea after days of constipation is not always relief. The NHS says leaking diarrhoea is the main sign of stuck stool.9 The Mounjaro medication guide says to tell your doctor about stomach problems that are severe or will not go away.11

Get help now: call 112 or go to an emergency department if you have stomach pain and cannot pass stool or wind. That is Australia's government health advice for a blocked bowel; 112 is India's emergency number.12 Separately, the Mounjaro medication guide's pancreatitis warning says to stop Mounjaro and call your healthcare provider right away for severe stomach pain that will not go away, sometimes felt in the back.11

Read the full picture

Related questions

How long do Mounjaro side effects last? Which symptoms on a GLP‑1 need urgent care? Can you drink alcohol on Mounjaro or Ozempic? What is tirzepatide? What should you do if you miss a dose of Ozempic or Mounjaro?
Did this answer your question?

Sources

  1. Eli Lilly. Zepbound (tirzepatide) US prescribing information, revised 08/2026. US label for tirzepatide's weight use (pool of SURMOUNT-1 and -2); not the Indian one. Section 6.1, Table 1. pi.lilly.com
  2. Eli Lilly. Mounjaro (tirzepatide) US prescribing information, revised 08/2026. US label, not the Indian one: we found no public Indian label. Sections 6.1 (Table 1), 6.2. pi.lilly.com
  3. Wharton S et al. Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss. Diabetes Obes Metab 2022;24:94-105. Pooled STEP 1-3; trials funded by Novo Nordisk. PMC9293236 · doi:10.1111/dom.14551 · PMID 34514682
  4. Chandra KP et al. Real-world evidence of tirzepatide in Indian adults with type 2 diabetes. Cureus 2026;18(2):e102866. Retrospective, 7 Lucknow centres, no comparison group. Six authors declared personal fees from Eli Lilly. PMC12961357 · doi:10.7759/cureus.102866 · PMID 41798487
  5. Gorgojo-Martínez JJ et al. Clinical recommendations to manage gastrointestinal adverse events in patients treated with GLP-1 receptor agonists: a multidisciplinary expert consensus. J Clin Med 2023;12(1):145. Section 4.3.4 and Figure 2. Funded by Novo Nordisk. PMC9821052 · doi:10.3390/jcm12010145 · PMID 36614945
  6. Mozaffarian D et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory (ACLM, ASN, OMA, TOS). Am J Clin Nutr 2025;122:344-367. "Management of GI side effects". Several authors report advisory or speaker roles with Novo Nordisk or Eli Lilly. doi:10.1016/j.ajcnut.2025.04.023 · PMC12612741
  7. Madhu SV, Kapoor N, Das S, Raizada N, Kalra S. ESI clinical practice guidelines for the evaluation and management of obesity in India: an update (2025). Indian J Endocrinol Metab 2025. Table 6. doi:10.4103/ijem.ijem_680_25 · PMID 40917319
  8. ICMR-National Institute of Nutrition. Dietary Guidelines for Indians, 2024. Pages 49 and 66. nin.res.in (PDF)
  9. NHS. Constipation (page last reviewed 26 Oct 2023). nhs.uk
  10. European Medicines Agency. Ozempic package leaflet (EU), section 4, "Serious side effects". ema.europa.eu
  11. Eli Lilly. Mounjaro US Medication Guide, revised August 2026. pi.lilly.com
  12. healthdirect Australia (Australian government health information service). Bowel obstruction (last reviewed September 2024). healthdirect.gov.au
  13. PIB Research. GLP-1 drugs: use, risks, and regulation (government backgrounder), 1 Apr 2026. pib.gov.in (PDF)
  14. CDSCO. Recommendations of the Subject Expert Committee (Endocrinology & Metabolism), 20-21 Apr 2023, tirzepatide item. cdsco.gov.in (PDF) · archived copy
  15. Novo Nordisk. Ozempic (semaglutide) US prescribing information, revised 05/2026. US label, not the Indian one. Section 6.1, table of adverse reactions in placebo-controlled type 2 diabetes trials. novo-pi.com

Last checked 5 Oct 2026 · Next review due 5 Oct 2027 · Report an error

How this answer was made. Written by the GLP Guidebook team from the sources above. It's general information, not medical advice. Talk to a qualified doctor before starting, stopping or changing any medicine. How we write